FIELD: medicine.
SUBSTANCE: in patient tears, cholestasis-indicating enzymes are determined, namely: alkaline phosphatase (APh), γ-glutamiltranspeptidase (γ-GTP), leucinaminopeptidase (LAP). If APh activity is ≥ 400.0 nmol/(s·l) or more, γ-GTP is ≥ 700.0 nmol/(s·l) or more, LAP is ≥ 52.5 Unit/l, the obstructive character of jaundice is diagnosed.
EFFECT: method allows exclusion of invasive component in jaundice laboratory diagnostics, simplifies analyses completion, and quicken the diagnostics.
1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2386134C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF NEONATAL HEPATITIS IN INFANTS | 2011 |
|
RU2488829C2 |
| METHOD FOR TREATING THE CASES OF TOXIC HEPATITIS IN PATIENTS SUFFERING FROM NARCOMANIA | 2001 |
|
RU2180598C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN ALCOHOLIC HEPATITIS | 2013 |
|
RU2559778C2 |
| METHOD FOR PREDICTING SEVERE JAUNDICE OF BENIGN GENESIS | 2018 |
|
RU2677468C1 |
| METHOD OF TREATING NON-ALCOHOLIC STEATOHEPATITIS WITH APPLICATION OF DALARGIN MAGNETOPHORESIS | 2011 |
|
RU2473325C1 |
| METHOD OF TREATING MODERATE AND SEVERE INTRAHEPATIC CHOLESTASIS OF PREGNANCY | 2010 |
|
RU2448716C2 |
| METHOD FOR TREATING THE PATIENTS SUFFERING FROM VIRAL HEPATITIS B WITH CHOLESTATIC COMPONENT | 2000 |
|
RU2165772C1 |
| AGENT NORMALISING LIVER MITOCHONDRIA | 2011 |
|
RU2470655C1 |
| METHOD FOR NEURORESUSCITATION PREDICTION OF CLINICAL OUTCOME OF TRAUMATIC INTRACRANIAL HEMATOMAS | 2011 |
|
RU2478208C1 |
